CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
78 hedge funds and large institutions have $1.44B invested in China Biologic Products Holdings, Inc. in 2015 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 30 increasing their positions, 18 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
20% more funds holding
Funds holding: 65 → 78 (+13)
75% less call options, than puts
Call options by funds: $1.54M | Put options by funds: $6.28M
Holders
78
Holding in Top 10
4
Calls
$1.54M
Puts
$6.28M
Top Buyers
| 1 | +$37.4M | |
| 2 | +$11.1M | |
| 3 | +$6.94M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$6.21M |
| 5 |
MICM
Matthews International Capital Management
San Francisco,
California
|
+$4.26M |
Top Sellers
| 1 | -$4.16M | |
| 2 | -$3.11M | |
| 3 | -$2.67M | |
| 4 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
-$2.57M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.29M |